Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Copley Acquisition Corp (COPL)

Copley Acquisition terminates Ignite Proteomics business combination agreement

Negative Impact 4 of 5 m&a Written later

Copley Acquisition Corp and Ignite Proteomics mutually agreed on October 9, 2026 to terminate their June 10, 2026 Business Combination Agreement. Copley says it intends to keep pursuing a business combination and has until November 2, 2026 to complete one, subject to extension under its organizational documents.

Key points

  • Business Combination Agreement with Ignite Proteomics, signed June 10, 2026, was terminated by mutual agreement on October 9, 2026.
  • Each party bears its own expenses, and the agreement includes mutual releases of claims tied to the terminated deal.
  • Copley's deadline to complete a business combination is November 2, 2026, subject to extension.
  • Filing warns Copley may have to redeem public shares and liquidate its trust account if it cannot complete another deal.

The filing

CompanyCopley Acquisition Corp (COPL)
Form8-K, current report
Filed with the SECOct 13, 2026, 5:00 PM ET
Accession number0001829126-26-011091

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.